MedTrace Logo

Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy

NCT00997633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2009-10-19

No results posted yet for this study

Summary

SPECT was performed in 51 patients after cytoreductive surgery in combination with intraperitoneal chemotherapy. The detected volume was compared to the number of subsequent sequential postoperative intraperitoneal chemotherapy courses that could be performed without further surgical intervention. SPECT data was found to predict feasibility of sequential postoperative intraperitoneal chemotherapy.

Conditions

  • Peritoneal Carcinomatosis

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Haile Mahteme, MD PhD · Dept of Surgical Sciences, University Hospital, Uppsala, Sweden

Eligibility

Min Age
14 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-05-31
Primary Completion
2004-08-31
Completion
2004-08-31

Countries

  • Sweden

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00997633 on ClinicalTrials.gov